Encision Inc
Encision Inc. designs and sells Active Electrode Monitoring (AEM) surgical instruments and related products that are intended to reduce the risk of stray electrosurgical energy during minimally invasive surgery. The company also offers disposable and multi-use laparoscopic scissors, monitors, and related accessories, and it supports adoption through direct sales, independent distributors, and hospital education efforts.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueMonopolar surgical instruments designed to monitor and reduce stray electrosurgical energy risk.
Disposable and multi-use laparoscopic scissors sold for hot and cold dissection.
Monitoring devices and related accessories that support the AEM product ecosystem.
Proof-of-concept and technical services tied to robotic and minimally invasive surgery.
Products
Reported · share of revenue- Products94.8 %
- Services5.2 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Encision sells primarily to hospitals, surgeons, and healthcare systems that perform minimally invasive and laparoscopic procedures. Adoption is driven by patient-safety concerns, clinical education, and hospital purchasing channels such as GPOs, integrated delivery networks, and the U.S. Veterans Affairs system.
Buy AEM instruments, scissors, and monitors to reduce electrosurgical injury risk and improve OR workflow.
Contract for broader hospital access and help standardize adoption across member facilities.
Purchase through system-wide sourcing agreements to standardize surgical products across facilities.
Use the company’s patient-safety technology in a large U.S. healthcare network.
Market products in Australia, New Zealand, and selected European markets where CE marking enables sales.
Strategy
Encision’s strategy is to broaden adoption of AEM technology by educating hospitals and surgeons about electrosurgical injury risk and by expanding its sales network. It is also trying to deepen access through GPOs, hospital systems, and distributors while using product innovation such as the 2X Scissors to widen use cases and improve value perception.
The company needs more operating-room penetration to drive recurring product sales.
Demand depends on convincing clinicians and hospitals that monitored electrosurgery reduces risk.
A lower-cost multi-use device can open new use segments and standardize customers on the portfolio.
CE marking and overseas distributors create incremental market opportunities beyond the U.S.
Geography
2025The company is headquartered in the United States and most of its business is focused on U.S. hospitals and surgical networks. International sales are still small, but it has distributors in Australia and New Zealand and CE marking allows access to Europe as distribution channels develop.
Share of the revenue the company reports by geography.
Risks
Encision’s business depends on convincing hospitals and surgeons to adopt a niche safety technology, so market acceptance and long sales cycles are central risks. It also faces supply-chain concentration, intense competition from larger electrosurgical manufacturers, regulatory oversight, cybersecurity exposure, and quarterly volatility typical of a small medical-device company.
- Limited market acceptance of AEM technologyImpact: HighLikelihood: High
Demand depends on educating hospitals about electrosurgical hazards and proving clinical value.
Exposure: Hospital operating rooms and laparoscopic surgery channels
- Supply chain concentrationImpact: HighLikelihood: Medium
The company relies on single-source suppliers and subcontractors for key components and assemblies.
Exposure: Manufacturing lead times and product availability
- Regulatory compliance and approval riskImpact: HighLikelihood: Medium
FDA and other agencies can inspect, restrict, or delay manufacturing and product approvals.
Exposure - Competitive pressure from larger medical-device companiesImpact: MediumLikelihood: High
Rivals have greater financial, technical, and marketing resources and entrenched products.
Exposure: Electrosurgical instruments and alternative surgical technologies
- Cybersecurity and data breach riskImpact: Medium
IT systems handle sensitive customer and employee information and could be disrupted or compromised.
Exposure
Accounting
Judgemental itemsProduct sales likely recognize when control transfers, so shipment timing can move revenue between quarters.
Impact: Affects quarterly comparability and reported growth rates
A focused product portfolio and long lead times increase the need to assess excess or obsolete stock.
Impact: Can affect gross margin and operating results
If adoption remains weak, asset values tied to product development or operations may need review.
Impact: Could create non-cash charges in weak periods
Small order sizes and hospital purchasing cycles can cause uneven revenue and expense recognition.
Impact: Makes trend analysis and guidance less predictable
Similar listed companies
Publicly listed companies with a comparable business focus.
ENvue Medical, Inc.
FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Stryker Corporation
SYK · Surgical & Medical Instruments & Apparatus
Zynex Inc
ZYXIQ · Electromedical & Electrotherapeutic Apparatus
Enovis CORP
ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Enovis is a U.S.-based medical technology company focused on orthopedic and musculoskeletal care.
Envoy Medical, Inc.
COCHW · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Nexalin Technology, Inc.
NXL · Electromedical & Electrotherapeutic Apparatus
Last updated: 24/09/2026